The biopharmaceutics classification system (BCS): Class III drugs — better candidates for BA/BE waiver?
- 1 December 1999
- journal article
- review article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 9 (2) , 117-121
- https://doi.org/10.1016/s0928-0987(99)00076-7
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- in Vitro-in Vivo Relationships of Several “Immediate” Release Tablets Containing a Low Permeability DrugPublished by Springer Nature ,1997
- The Effect of Mannitol on the Oral Bioavailability of CimetidineJournal of Pharmaceutical Sciences, 1995
- A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo BioavailabilityPharmaceutical Research, 1995